Urology · Vineland, NJ
NPI
1013901693
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2950 College Dr, Suite 2e
Vineland, NJ, 08360
Phone (856) 405-0025
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
17,216 services
Medicare patients, 2024
647
Average age 75
Drug cost, 2024
$805K
5,611 prescriptions
Company payments, 2025
$1,621
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher S Lee was code J0897 (injection, denosumab, 1 mg), 6,360 times for 25 patients. In total Christopher S Lee billed 17,216 services in 128 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 6,360 | 25 | $20.53 | $131K |
| 99214 Office E&M - Established | Office | 1,119 | 542 | $96.94 | $108K |
| 93975 Duplex Scan - Extremity Arteries | Office | 404 | 336 | $208.73 | $84K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 334 | 63 | $0.36 | $119 |
| 51798 Ultrasound - Nonspecific | Office | 313 | 197 | $9.24 | $2,892 |
| 96372 Injection Administration | Office | 312 | 91 | $11.44 | $3,570 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 292 | 283 | $44.22 | $13K |
| 51741 Test - Miscellaneous | Office | 272 | 176 | $6.33 | $1,721 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 254 | 244 | $89.05 | $23K |
| 99231 Hospital E&M - Subsequent | Facility | 230 | 52 | $38.96 | $8,961 |
| 51700 Other Organ Systems | Facility | 225 | 59 | $23.13 | $5,204 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 210 | 21 | $138.65 | $29K |
| 76870 Ultrasound - Nonspecific | Office | 200 | 154 | $69.84 | $14K |
| 93976 Duplex Scan - Extremity Arteries | Office | 191 | 184 | $116.49 | $22K |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 148 | 51 | $1.92 | $284 |
By year: 2022 $879K for 11,489 services; 2023 $887K for 16,284 services; 2024 $1.0M for 17,216 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88112 Surgical Pathology Examination | 113 | 81 | $44.86 | $5,069 |
| 88344 Immunohistochemistry | 90 | 31 | $140.30 | $13K |
| G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 51 | 45 | $252.64 | $13K |
| 88342 Immunohistochemistry | 34 | 29 | $26.35 | $896 |
| 88360 Immunohistochemistry | 33 | 28 | $31.28 | $1,032 |
| 88121 Surgical Pathology Examination | 33 | 27 | $36.45 | $1,203 |
| 81003 Clinical Chemistry | 20 | 19 | $2.20 | $44 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher S Lee prescribed most often to Medicare patients was Alfuzosin Hcl Er (Alfuzosin Hcl), with 1,916 prescriptions and refills. In total Christopher S Lee wrote 5,611 Medicare prescriptions that cost $805K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alfuzosin Hcl Er Alfuzosin Hcl | 1,916 | 5,483 | 641 | $58K |
| Finasteride Generic | 1,423 | 4,064 | 433 | $23K |
| Levofloxacin Generic | 588 | 598 | 455 | $4,061 |
| Tamsulosin Hcl Generic | 246 | 689 | 86 | $6,913 |
| Myrbetriq Mirabegron | 238 | 608 | 87 | $262K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 195 | 545 | 71 | $7,406 |
| Testosterone Cypionate Generic | 154 | 384 | 49 | $12K |
| Solifenacin Succinate Generic | 142 | 415 | 68 | $7,818 |
| Estradiol Generic | 138 | 359 | 62 | $11K |
| Cefdinir Generic | 85 | 87 | 72 | $1,121 |
| Gemtesa Vibegron | 56 | 124 | 20 | $58K |
| Bicalutamide Generic | 49 | 131 | 28 | $1,917 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 40 | 47 | 26 | $1,736 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 38 | 38 | 34 | $162 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 28 | 82 | 12 | $3,415 |
Brand drugs: - claims; generic drugs: 5,274 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher S Lee $1,621 ($1,621 in general payments such as food, travel and fees) from 23 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $228.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $228 |
| Immunitybio, Inc. IBRX | 1 | $150 |
| Tolmar, Inc. | 9 | $148 |
| Dendreon Pharmaceuticals LLC | 6 | $101 |
| Olympus America Inc. | 3 | $98.12 |
| Urogen Pharma, Inc. URGN | 2 | $95.57 |
| Ferring Pharmaceuticals Inc. | 4 | $75 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $72.87 |
| Cook Medical LLC | 1 | $64.56 |
| Astellas Pharma US Inc 4503.T | 3 | $62.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.